Orion Biotechnology Canada Ltd. announced it raised $5.44 Million in an amended filing from an offering of $15 Million
Orion Biotechnology Canada Ltd. announced it raised $5.44 Million in an amended filing from an offering of $15 Million
06/22/21, 12:51 PM
Location
ottawaMoney raised
$5.44 million
Industry
biotechnology
Company Info
Location
343 preston street, 11th floor
ottawa, ontario, canada
Additional Info
Orion is a clinical stage company leveraging a proprietary technology platform to develop next generation therapeutics for effectively targeting G Protein-Coupled Receptors (GPCRs). Orion’s platform enables effectively targeting previously undruggable complex GPCRs. Our pipeline includes 3 next generation therapeutics for cancer including our lead candidate - OB-002 – which is a first-in-class cancer immunotherapy with best-in-class potency.